Search

everythinglearnresearchcommunity

for

Search:↓

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Tislelizumab can cause cutaneous lupus erythematosus.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

HPV infection is linked to better survival in advanced anal cancer, higher radiation doses improve survival, especially in HPV-negative patients, and prostaglandin E₂ pretreatment can protect mouse hair follicles from radiation damage.

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Skin reactions from cancer treatments might predict how well the treatments work.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Lung cancer patients on immunotherapy and chemotherapy often experience severe fatigue, drowsiness, and appetite loss.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Essential oils can boost athletic performance by improving brain function and muscle relaxation.

The girl's regrown brown hair had less of certain pigments than her original black hair.

The anesthesia protocol with fentanyl and propofol caused the least pain during septoplasty.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

Physical activity increased, but sedentary behavior also rose, especially in men.

3D models and organoids improve liposarcoma research and therapy development.

Early intervention and patient education are crucial for managing alopecia areata.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Hair shaft miniaturization leads to hair follicle stem cell loss, suggesting Piezo1 as a potential treatment target.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

CD34 is absent in most basal cell carcinoma cells but present in surrounding skin.

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.

Elderly women in Northern Russia have higher anxiety and different brain energy patterns than men.

The review emphasizes the need to recognize skin conditions that affect hair follicles and sweat glands to avoid misdiagnosis.